Analysis of American Diabetes Association Recommended Chronic Therapy Inpatient Interventions by Pharmacists

Analysis of American Diabetes Association Recommended Chronic Therapy Inpatient Interventions by Pharmacists. 

Amanda Jensen, Pharm.D.,¹ Thaddaus Hellwig, Pharm.D., BCPS,^1,2 Megan Maddox, Pharm.D., BCPS, CDE. Sanford USD Medical Center, Sioux Falls, SD,¹ South Dakota State University College of Pharmacy.²

Objectives:   Evaluate the effectiveness of pharmacist interventions in initiating American Diabetes Association (ADA) recommended therapies for prevention of long-term complications.  The primary objective is to determine the baseline rates of ADA recommended therapies for all adult diabetic patients admitted to Sanford USD Medical Center during the month of January 2012.  A secondary objective is to determine acceptance rates of recommendations prior to patient discharge.

Methods:  Prospective, single center, chart review of all adult inpatient diabetics on a daily basis during January 2012. An evaluation of the patient's medical record for ADA recommended therapies will take place.  If a patient would be a candidate for ADA recommended preventative therapies (specifically use of aspirin, statins, and ACE inhibitors/ARB medications) a recommendation will be communicated to providers via the electronic medical record.  Acceptance rates of recommendations will be collected at patient discharge.

Results: An analysis of the first twenty patients in the study demonstrated a total of 19 recommendations to initiate ADA recommended therapies, approximately 1 recommendation per patient.  Four of the 19 (21%) recommendations were accepted prior to patient discharge. Further data collection currently in progress.

Conclusion: Data collection currently in progress and scheduled to be completed by January 31^st, 2012.